Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Oncoimmunology|September 5, 2025
Divergent on-target off-tumor effects by CAR T and CAR NK cells suggest different efficacy and safety of cell therapiesKatharina Schindler-Wnek, Anika Stahringer, Nadine Heimer, et al.
Proteomics|October 29, 2015
Redox proteomics: Methods for the identification and enrichment of redox-modified proteins and their applicationsClaudia Lennicke, Jette Rahn, Nadine Heimer, et al.
Methods in Enzymology|March 18, 2020
An altered miTRAP method for miRNA affinity purification with its pros and consSimon Jasinski-Bergner, Christoforos Vaxevanis, Nadine Heimer, et al.
Cellular and Molecular Life Sciences : CMLS|April 30, 2020
What turns CREB on? And off? And why does it matter?André Steven, Michael Friedrich, Paul Jank, et al.
Methods in Enzymology|March 18, 2020
Identification of immunomodulatory RNA-binding proteins in tumorsMichael Friedrich, Maria-Filothei Lazaridou, Jette Rahn, et al.
Scientific Reports|April 18, 2020
CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinomaMichael Friedrich, Nadine Heimer, Christine Stoehr, et al.
International Journal of Molecular Sciences|September 30, 2020
Expression, Regulation and Function of microRNA as Important Players in the Transition of MDS to Secondary AML and Their Cross Talk to RNA-Binding ProteinsMarcus Bauer, Christoforos Vaxevanis, Nadine Heimer, et al.
Pageof 1